Session 9
Tuesday, 27 September 2022 | 15:00-16:30 | Conference Centre
The Oslo Medicines Initiative (OMI) was launched in 2020 as a collaboration between the WHO European Region and the Government of Norway, as part of the European Programme of Work, United Action for Better Health.
The OMI underscores the importance of collaboration between the public and private sectors, and other key stakeholders, to develop potential joint solutions for improving access to novel medicines.
This session will celebrate the achievements of the OMI and will highlight some key policy considerations that can be explored further to advance the access to novel medicines agenda.